Amid global trade uncertainties and shifting U.S. tariff policies, multinational pharmaceutical companies are increasingly looking to China as a major hub for innovation and growth. At this year's China International Import Expo, many Fortune Global 500 drugmakers are unveiling cutting-edge therapies, medical devices and digital healthcare technologies. It's also where China is demonstrating its expanding role as a global biopharma innovation center.